SCHEMBL4687745

SCHEMBL4687745

NC1CN(C(=O)C2CC2)CCC1C(=O)Nc1ccc(-n2ccccc2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
F10 P00742 16/20 0.50
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
RXRG P48443 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5435577 0.89 F10 (0.54) F10
SCHEMBL5437823 0.82 F10 (0.47) F10
SCHEMBL5436168 0.81 F10 (0.61) F10
SCHEMBL5432660 0.81 F10 (0.67) F10
SCHEMBL5435959 0.80 F10 (0.56) F10
SCHEMBL4807697 0.80 F10 (0.54) F10
SCHEMBL4744904 0.78 F10 (0.62) F10
SCHEMBL5438654 0.76 F10 (0.65) F10
SCHEMBL5438656 0.76 F10 (0.65) F10
SCHEMBL4741955 0.76 F10 (0.65) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603572-A4 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2008-06-25 EP disclosed
EP-1603572-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-12-14 EP disclosed
WO-2004082687-A1 LACTAM-CONTAINING CYCLIC DIAMINES AND DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-09-30 WO disclosed